Loading...

Estia Health

DB:26E
Snowflake Description

Undervalued with mediocre balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
26E
DB
A$740M
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

Estia Health Limited engages in the development and operation of owned and leased residential aged care homes in Australia. The last earnings update was 54 days ago. More info.


Add to Portfolio Compare Print
26E Share Price and Events
7 Day Returns
-0.5%
DB:26E
-4.7%
DE Healthcare
1.8%
DE Market
1 Year Returns
-16.2%
DB:26E
-21.4%
DE Healthcare
-6%
DE Market
26E Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Estia Health (26E) -0.5% 4.9% 32.7% -16.2% -55.2% -
DE Healthcare -4.7% -0.5% 12.1% -21.4% -18.6% 37.3%
DE Market 1.8% 4.2% 7.4% -6% 10.1% 15.4%
1 Year Return vs Industry and Market
  • 26E outperformed the Healthcare industry which returned -21.4% over the past year.
  • 26E underperformed the Market in Germany which returned -6% over the past year.
Price Volatility
26E
Industry
5yr Volatility vs Market

26E Value

 Is Estia Health undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Estia Health to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Estia Health.

DB:26E Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 6 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 5.3%
Perpetual Growth Rate 10-Year DE Government Bond Rate 0.2%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for DB:26E
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate 0.2%
Equity Risk Premium S&P Global 6%
Healthcare Unlevered Beta Simply Wall St/ S&P Global 0.71
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.711 (1 + (1- 30%) (10.99%))
0.843
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.84
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.23% + (0.843 * 5.96%)
5.25%

Discounted Cash Flow Calculation for DB:26E using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Estia Health is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

DB:26E DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (AUD, Millions) Source Present Value
Discounted (@ 5.25%)
2019 -9.35 Analyst x2 -8.88
2020 -34.65 Analyst x2 -31.28
2021 38.00 Analyst x2 32.59
2022 71.34 Analyst x1 58.13
2023 101.87 Est @ 42.79% 78.86
2024 132.45 Est @ 30.02% 97.42
2025 160.38 Est @ 21.08% 112.07
2026 184.16 Est @ 14.83% 122.26
2027 203.40 Est @ 10.45% 128.30
2028 218.41 Est @ 7.38% 130.89
Present value of next 10 years cash flows A$720.37
DB:26E DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= A$218.41 × (1 + 0.23%) ÷ (5.25% – 0.23%)
A$4,356.03
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= A$4,356.03 ÷ (1 + 5.25%)10
A$2,610.54
DB:26E Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= A$720.37 + A$2,610.54
A$3,330.91
Equity Value per Share
(AUD)
= Total value / Shares Outstanding
= A$3,330.91 / 260.60
A$12.78
DB:26E Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in DB:26E represents 0.6169x of ASX:EHE
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.6169x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (AUD) x Listing Adjustment Factor
= A$ 12.78 x 0.6169
€7.88
Value per share (EUR) From above. €7.88
Current discount Discount to share price of €1.75
= -1 x (€1.75 - €7.88) / €7.88
77.8%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Estia Health is available for.
Intrinsic value
>50%
Share price is €1.75 vs Future cash flow value of €7.88
Current Discount Checks
For Estia Health to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Estia Health's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Estia Health's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Estia Health's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Estia Health's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:26E PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in AUD A$0.16
ASX:EHE Share Price ** ASX (2019-04-18) in AUD A$2.84
Germany Healthcare Industry PE Ratio Median Figure of 10 Publicly-Listed Healthcare Companies 34.55x
Germany Market PE Ratio Median Figure of 422 Publicly-Listed Companies 19.59x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Estia Health.

DB:26E PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= ASX:EHE Share Price ÷ EPS (both in AUD)

= 2.84 ÷ 0.16

17.64x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Estia Health is good value based on earnings compared to the DE Healthcare industry average.
  • Estia Health is good value based on earnings compared to the Germany market.
Price based on expected Growth
Does Estia Health's expected growth come at a high price?
Raw Data
DB:26E PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 17.64x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 6 Analysts
0.3%per year
Germany Healthcare Industry PEG Ratio Median Figure of 7 Publicly-Listed Healthcare Companies 1.31x
Germany Market PEG Ratio Median Figure of 270 Publicly-Listed Companies 1.57x

*Line of best fit is calculated by linear regression .

DB:26E PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 17.64x ÷ 0.3%

51.56x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Estia Health is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on Estia Health's assets?
Raw Data
DB:26E PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in AUD A$2.92
ASX:EHE Share Price * ASX (2019-04-18) in AUD A$2.84
Germany Healthcare Industry PB Ratio Median Figure of 12 Publicly-Listed Healthcare Companies 1.5x
Germany Market PB Ratio Median Figure of 570 Publicly-Listed Companies 1.84x
DB:26E PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= ASX:EHE Share Price ÷ Book Value per Share (both in AUD)

= 2.84 ÷ 2.92

0.97x

* Primary Listing of Estia Health.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Estia Health is good value based on assets compared to the DE Healthcare industry average.
X
Value checks
We assess Estia Health's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Estia Health has a total score of 5/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

26E Future Performance

 How is Estia Health expected to perform in the next 1 to 3 years based on estimates from 6 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
0.3%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Estia Health expected to grow at an attractive rate?
  • Estia Health's earnings growth is expected to exceed the low risk savings rate of 0.2%.
Growth vs Market Checks
  • Estia Health's earnings growth is positive but not above the Germany market average.
  • Estia Health's revenue growth is expected to exceed the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:26E Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:26E Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 6 Analysts 0.3%
DB:26E Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 6 Analysts 5.1%
Germany Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 3.1%
Germany Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 5.4%
Germany Market Earnings Growth Rate Market Cap Weighted Average 11.5%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.8%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:26E Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below
All numbers in AUD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:26E Future Estimates Data
Date (Data in AUD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2022-06-30 688 43 1
2021-06-30 642 107 44 6
2020-06-30 611 107 42 6
2019-06-30 583 87 44 6
DB:26E Past Financials Data
Date (Data in AUD Millions) Revenue Cash Flow Net Income *
2018-12-31 565 105 42
2018-09-30 556 121 42
2018-06-30 547 137 41
2018-03-31 540 138 41
2017-12-31 533 139 41
2017-09-30 529 139 41
2017-06-30 525 139 41
2017-03-31 517 148 36
2016-12-31 510 158 31
2016-09-30 476 150 29
2016-06-30 443 142 28
2016-03-31 400 146 27

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Estia Health's earnings are expected to grow by 0.3% yearly, however this is not considered high growth (20% yearly).
  • Estia Health's revenue is expected to grow by 5.1% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:26E Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below

All data from Estia Health Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:26E Future Estimates Data
Date (Data in AUD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2022-06-30 0.16 0.16 0.16 1.00
2021-06-30 0.17 0.18 0.16 5.00
2020-06-30 0.16 0.17 0.16 4.00
2019-06-30 0.16 0.18 0.15 4.00
DB:26E Past Financials Data
Date (Data in AUD Millions) EPS *
2018-12-31 0.16
2018-09-30 0.16
2018-06-30 0.16
2018-03-31 0.16
2017-12-31 0.16
2017-09-30 0.17
2017-06-30 0.18
2017-03-31 0.17
2016-12-31 0.16
2016-09-30 0.16
2016-06-30 0.15
2016-03-31 0.15

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Estia Health is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Estia Health's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Estia Health has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

26E Past Performance

  How has Estia Health performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Estia Health's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Estia Health has delivered over 20% year on year earnings growth in the past 5 years.
  • Estia Health's 1-year earnings growth is less than its 5-year average (1.9% vs 57%)
  • Estia Health's earnings growth has not exceeded the DE Healthcare industry average in the past year (1.9% vs 12.5%).
Earnings and Revenue History
Estia Health's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Estia Health Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:26E Past Revenue, Cash Flow and Net Income Data
Date (Data in AUD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 564.84 41.98 39.22
2018-09-30 555.89 41.57 38.19
2018-06-30 546.93 41.15 37.15
2018-03-31 540.10 41.18 36.53
2017-12-31 533.26 41.20 35.90
2017-09-30 528.95 40.95 36.23
2017-06-30 524.63 40.70 36.56
2017-03-31 517.38 35.61 34.88
2016-12-31 510.13 30.51 33.20
2016-09-30 476.47 29.08 31.39
2016-06-30 442.82 27.64 29.57
2016-03-31 399.71 27.40 16.91
2015-12-31 356.59 27.16 4.24
2015-09-30 320.69 2.32 11.65
2015-06-30 284.80 -22.52 19.06
2015-03-31 227.93 -30.16 29.22
2014-12-31 171.07 -37.79 39.38
2014-09-30 118.95 -26.13 22.68
2014-06-30 66.83 -14.47 5.99

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Estia Health has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Estia Health used its assets less efficiently than the DE Healthcare industry average last year based on Return on Assets.
  • Estia Health's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Estia Health's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Estia Health has a total score of 1/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

26E Health

 How is Estia Health's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Estia Health's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Estia Health's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Estia Health's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Estia Health's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is not covered by short term assets, assets are 0.4x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Estia Health Company Filings, last reported 3 months ago.

DB:26E Past Debt and Equity Data
Date (Data in AUD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 761.80 81.34 15.23
2018-09-30 761.80 81.34 15.23
2018-06-30 761.56 76.37 11.20
2018-03-31 761.56 76.37 11.20
2017-12-31 760.79 61.26 17.71
2017-09-30 760.79 61.26 17.71
2017-06-30 761.12 122.81 19.22
2017-03-31 761.12 122.81 19.22
2016-12-31 673.34 267.38 86.24
2016-09-30 673.34 267.38 86.24
2016-06-30 591.68 254.18 29.81
2016-03-31 591.68 254.18 29.81
2015-12-31 558.74 146.50 45.76
2015-09-30 558.74 146.50 45.76
2015-06-30 563.91 54.25 47.09
2015-03-31 563.91 54.25 47.09
2014-12-31 553.73 0.00 36.67
2014-09-30 553.73 0.00 36.67
2014-06-30 53.78 116.81 4.62
  • Estia Health's level of debt (10.7%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if Estia Health's debt level has increased without past 5-year debt data.
  • Debt is well covered by operating cash flow (128.9%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 13.3x coverage).
X
Financial health checks
We assess Estia Health's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Estia Health has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

26E Dividends

 What is Estia Health's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
5.63%
Current annual income from Estia Health dividends. Estimated to be 5.78% next year.
If you bought €2,000 of Estia Health shares you are expected to receive €113 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Estia Health's pays a higher dividend yield than the bottom 25% of dividend payers in Germany (1.43%).
  • Estia Health's dividend is above the markets top 25% of dividend payers in Germany (3.72%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:26E Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below
Germany Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 10 Stocks 1.6%
Germany Market Average Dividend Yield Market Cap Weighted Average of 326 Stocks 3%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.4%
Germany Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:26E Future Dividends Estimate Data
Date (Data in A$) Dividend per Share (annual) Avg. No. Analysts
2022-06-30 0.16 1.00
2021-06-30 0.17 6.00
2020-06-30 0.16 6.00
2019-06-30 0.17 6.00
DB:26E Past Annualized Dividends Data
Date (Data in A$) Dividend per share (annual) Avg. Yield (%)
2019-02-25 0.160 6.245
2018-08-15 0.160 6.798
2018-02-21 0.156 4.650
2017-08-23 0.080 2.345
2017-02-22 0.000 0.000
2016-08-29 0.256 9.065
2016-02-18 0.256 4.802
2015-08-11 0.136 1.950

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Whilst dividend payments have been stable, Estia Health has been paying a dividend for less than 10 years.
  • Dividend payments have increased, but Estia Health only paid a dividend in the past 4 years.
Current Payout to shareholders
What portion of Estia Health's earnings are paid to the shareholders as a dividend.
  • Dividends paid are not well covered by earnings (1x coverage).
Future Payout to shareholders
  • Dividends after 3 years are not well covered by earnings (1x coverage).
X
Income/ dividend checks
We assess Estia Health's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Estia Health afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Estia Health has a total score of 2/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

26E Management

 What is the CEO of Estia Health's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Ian Thorley
COMPENSATION A$597,275
TENURE AS CEO 0.5 years
CEO Bio

Mr. Ian Thorley is Chief Executive Officer at Estia Health Limited since October 2018 and id its Managing Director. Mr. Thorley was the Chief Operating Officer of Estia Health Limited since October 24, 2016 until October 2018 and was its Deputy Chief Executive Officer since March 25, 2017 until October 2018. Mr. Thorley served as the Chief Operating Officer of Opal Aged Care (Alternative Names: The Domain Principal Group and Domain Aged Care Group,). He was responsible for the efficient and effective delivery of the Domain and Principal service delivery models within a national operating framework. With over 30 years health and aged care experience in both Australia and overseas, his previous executive roles have included Chief Executive Officer and Chief Operating Officer of acute private hospital groups, diagnostic services and aged and community care. He has been at the forefront of major developments that have shaped the private healthcare sector in Australia including the privatization of public hospitals, new reimbursement and funding models, funding of academic positions by the private sector and co-located public/private sector service models. Internationally, he has managed diagnostic and acute healthcare businesses in the UK and UAE as well as researching and developing health care investment opportunities in emerging health economies in Eastern Europe. He has consulted to private hospitals, health insurers, health logistics and specialist health recruitment businesses throughout Australia and has held non-executive roles in private healthcare and ASX listed companies. Mr. Ian is a Graduate of the Australian Institute of Company Directors (GAICD) and holds a Master of Commerce from the University of NSW.

CEO Compensation
  • Ian's compensation has increased by more than 20% in the past year.
  • Ian's remuneration is lower than average for companies of similar size in Germany.
Management Team Tenure

Average tenure of the Estia Health management team in years:

1.6
Average Tenure
  • The average tenure for the Estia Health management team is less than 2 years, this suggests a new team.
Management Team

Ian Thorley

TITLE
CEO & MD
COMPENSATION
A$597K
TENURE
0.5 yrs

Steve Lemlin

TITLE
Chief Financial Officer
COMPENSATION
A$542K
TENURE
2.2 yrs

Sean Bilton

TITLE
COO & Deputy CEO
TENURE
0.5 yrs

Fiona Caldwell

TITLE
Chief Information Officer
TENURE
1.5 yrs

Suzy Watson

TITLE
General Counsel
TENURE
4.3 yrs

Jane Murray

TITLE
Chief People Officer
TENURE
1.8 yrs

Mark Brandon

TITLE
Chief Policy & Regulatory Officer
TENURE
2.3 yrs

Mary Burke

TITLE
Chief Quality & Risk Officer

Damian Hiser

TITLE
Chief Customer Officer
TENURE
1.5 yrs

Leanne Ralph

TITLE
Company Secretary
Board of Directors Tenure

Average tenure and age of the Estia Health board of directors in years:

2.1
Average Tenure
59.5
Average Age
  • The average tenure for the Estia Health board of directors is less than 3 years, this suggests a new board.
Board of Directors

Gary Weiss

TITLE
Non-Executive Chairman
COMPENSATION
A$271K
AGE
65
TENURE
2.3 yrs

Paul Foster

TITLE
Non-Executive Director
COMPENSATION
A$135K
AGE
49
TENURE
3.2 yrs

Warwick Smith

TITLE
Non-Executive Director
COMPENSATION
A$125K
TENURE
1.9 yrs

Helen Kurincic

TITLE
Non-Executive Director
COMPENSATION
A$125K
TENURE
1.8 yrs

Karen Lee Penrose

TITLE
Director
AGE
58
TENURE
0.5 yrs

Norah Barlow

TITLE
Director
COMPENSATION
A$1M
AGE
61
TENURE
4.4 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by Estia Health insiders in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
08. Apr 19 Buy Karen Lee Penrose Individual 05. Apr 19 05. Apr 19 6,000 €1.71 €10,230
18. Mar 19 Buy Ian Thorley Individual 13. Mar 19 15. Mar 19 50,000 €1.51 €75,712
06. Mar 19 Sell Perpetual Limited Company 04. Mar 19 04. Mar 19 -7,573,139 €1.48 €-11,182,880
05. Mar 19 Buy Karen Lee Penrose Individual 01. Mar 19 01. Mar 19 8,333 €1.49 €12,430
01. Mar 19 Buy Perpetual Limited Company 20. Sep 18 27. Feb 19 2,705,893 €1.42 €3,838,466
07. Dec 18 Sell Vinva Investment Management Company 05. Aug 18 05. Dec 18 -100,113 €1.47 €-146,785
07. Dec 18 Buy Vinva Investment Management Company 05. Aug 18 05. Dec 18 524,037 €1.47 €771,214
21. Sep 18 Buy Perpetual Limited Company 29. Aug 18 19. Sep 18 2,728,699 €1.73 €4,710,143
10. Sep 18 Buy Paul Foster Individual 07. Sep 18 07. Sep 18 10,000 €1.82 €18,186
30. Aug 18 Sell Perpetual Limited Company 24. May 18 21. Aug 18 -1,401,943 €2.02 €-2,828,300
30. Aug 18 Buy Perpetual Limited Company 31. May 18 28. Aug 18 4,191,045 €1.89 €7,929,258
10. May 18 Buy Credit Suisse, Investment Banking and Securities Investments Company 31. Jan 18 04. May 18 3,039 €2.19 €6,645
03. May 18 Sell Perpetual Limited Company 06. Apr 17 27. Apr 18 -18,860,940 €2.15 €-40,489,422
03. May 18 Buy Perpetual Limited Company 02. Mar 17 24. Apr 18 9,762,716 €2.01 €19,648,425
X
Management checks
We assess Estia Health's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Estia Health has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

26E News

Simply Wall St News

26E Company Info

Description

Estia Health Limited engages in the development and operation of owned and leased residential aged care homes in Australia. It has 68 facilities in 5,910 operating places in Victoria, South Australia, New South Wales, and Queensland. The company was founded in 2005 and is based in Sydney, Australia.

Details
Name: Estia Health Limited
26E
Exchange: DB
Founded: 2005
A$470,513,633
260,602,749
Website: http://www.estiahealth.com.au
Address: Estia Health Limited
227 Elizabeth Street,
Level 9,
Sydney,
New South Wales, 2000,
Australia
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
ASX EHE Ordinary Shares Australian Securities Exchange AU AUD 05. Dec 2014
DB 26E Ordinary Shares Deutsche Boerse AG DE EUR 05. Dec 2014
Number of employees
Current staff
Staff numbers
0
Estia Health employees.
Industry
Health Care Facilities
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/20 21:48
End of day share price update: 2019/04/18 00:00
Last estimates confirmation: 2019/04/08
Last earnings filing: 2019/02/25
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/06/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.